Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 46 % of short-term debt in 2026; threshold 65 %.
Financials
Financial year 2026
APOTHEEK NOORDERLAAN from Antwerpen, company number BE0894785309, closed financial year 2026 with a result of € -132,472 after tax. For that financial year APOTHEEK NOORDERLAAN recorded a gross margin of € 272,744 and equity of € 853,762. Compared with financial year 2025, the result moved from € 55,370 to € -132,472. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 21, 2026.
€ 853,762
▼ 13% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -132,472
▼ still € 55,370 profit in 2025
Profit after tax over the fiscal year.
€ 12,518
▲ 28% vs 2025
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 238,946.
People and assets in 2026
3.5
▲ 0.3 vs 2025
Average over the fiscal year, from the social balance sheet.
€ 242,452
▲ 23% vs 2025
€ 69,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,435
▼ 68% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 230,988
▲ 23% vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 14,474
▼ 26% vs 2025
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 430,428 | € 631,633 | € 406,425 | € 272,744 | ▼ 33% |
| Profit after taxes | € 136,623 | € 116,566 | € 55,370 | € -132,472 | ▼ € 187,841 |
| Equity | € 914,298 | € 1,030,864 | € 986,234 | € 853,762 | ▼ 13% |
| Total debts | € 648,356 | € 164,087 | € 212,073 | € 463,558 | ▲ 119% |
| Cash | € 387,326 | € 24,104 | € 9,804 | € 12,518 | ▲ 28% |
| Land & buildings | € 580,704 | € 534,906 | € 508,746 | € 759,680 | ▲ 49% |
| Retained profit | € 299,482 | € 416,048 | € 371,418 | € 238,946 | ▼ 36% |
| Dividend | € 105,000 | € 0 | € 100,000 | € 0 | ▼ 100% |
| Bank debt | € 442,837 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 1,562,654 | € 1,194,950 | € 1,198,306 | € 1,317,320 | ▲ 10% |
| Employees (FTE) | 3.2 | 4.8 | 3.2 | 3.5 | ▲ 0.3 |
Key figures of APOTHEEK NOORDERLAAN, fiscal years 2022 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to APOTHEEK NOORDERLAAN?
What happened at APOTHEEK NOORDERLAAN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: loss of € 132,472 (▼ € 187,841 vs 2025). Source: NBB ↗
- MICHAEL HAMELRIJCK became a director. NBB
- Stefaan Vandamme stepped down as director. NBB
- Stefan Goethaert became a director. NBB
- Jo Willemyns became a director. NBB
- Kris Castelein became a director. NBB
- Jozef Colruyt became a director. NBB
- Stefaan Vandamme became a director. NBB
In short
From € 136,623 profit in 2022 to € 132,472 loss in 2026.
Paid € 64,238 in corporate taxes since 2022.
Best year ever: 2022, with € 136,623 profit.
On average € 77,900 of value added per employee in 2026.
A new publication or filing at APOTHEEK NOORDERLAAN? We notify you, reason included.
Follow APOTHEEK NOORDERLAANDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of NEWPHARMA GROUP comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK NOORDERLAANBehind APOTHEEK NOORDERLAAN are MICHAEL HAMELRIJCK, Stefan Goethaert, Jo Willemyns, Kris Castelein and Jozef Colruyt. The shares are held by NEWPHARMA GROUP (100%).
Directors
According to the 2026 annual accounts
MICHAEL HAMELRIJCK
Director
since 2026
Stefan Goethaert
Director
since 2023
Jo Willemyns
Director
since 2023
Kris Castelein
Director
since 2023
Jozef Colruyt
Director
since 2023
Stefaan Vandamme
Director
since 2023 · until 2026
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Noorderlaan 104 box h
2030 Antwerpen
Noorderlaan 104
2030 Antwerpen
Active since 1 January 2008
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
AMAZON-02 - Amazon.com, Inc., US
Domain
Domain
aponoord.be
Registered
2016-09-02
Website info
Features
Security
Details
- Company number
- 0894.785.309
- VAT number
- BE 0894.785.309
- Registered office
- Noorderlaan 104 bus h, 2030 Antwerpen
- Names & denominations
- APOTHEEK NOORDERLAAN
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 18 December 2007
- Peppol
- Active · Active since 24 Nov 2023
- Activities · NACE
Detailhandel in farmaceutische producten